Fashion platforms and beauty brands used large-scale offline events not merely for promotion but as tools to drive sales conversion. In Musinsa’s case, more than 31,000 people visited its Seongsu event, and online transaction value jumped 246% from a year earlier, showing how on-site experiences translated directly into increased online purchases. This trend has expanded beyond individual companies to city-level events as well. In programs linked to Seoul Beauty Week, product trials, influencer content creation, and export consultations were combined in one space, while 111 overseas buyers from 47 countries took part, reinforcing a structure in which branding and distribution channel expansion happen simultaneously...

Local governments and the medical community are moving to expand support for postpartum recovery. Suwon’s broader postpartum support shows a trend toward incorporating Korean medicine treatment into birth-friendly policy, and in practice, a safety study tracking 186 postpartum women, though limited, is helping strengthen the evidence for its use... By contrast, stricter standards are being applied to cost control and the appropriiateness of coverage. Auto insurance medical expenses swelled to 1.5057 trillion won, fueling controversy over the overuse of Korean medicine treatment, and courts also made clear the boundaries of institutional reimbursement by refusing to recognize National Health Insurance claims for herbal preparations sold without a prescription...

Recent moves by health authorities and audit agencies are converging on strengthening verification systems rather than simply expanding technology adoption. The Ministry of Food and Drug Safety’s certification for outstanding AI digital medical device companies grants review privileges to firms with proven development capabilities while still requiring them to demonstrate post-market validity, and criticisms over duplicate construction and poor quality of public AI training data reflect the same trend. This shift reflects a growing view that as industries expand rapidly, the reliability of data and clinical operations forms the foundation of competitiveness. Going forward, speed alone in launching technology will be less of a differentiator, while companies with standardized data management and strong clinical quality assurance are likely to gain an advantage in regulatory response and business expansion.

Evidence is growing that menopause should be treated not as the point when uncomfortable symptoms begin, but as a turning point that shapes the risk of chronic disease over the following decades. Data tracking more than 5,000 women aged 42 to 52 in a national cohort show that metabolic changes begin not after menopause, but during the transition period when menstrual cycles first become irregular. This also suggests that an approach focused only on individual symptoms in women’s health has reached its limits. Cardiovascular disease in women more often involves microvascular abnormalities and may appear without typical chest pain; related research found microvascular dysfunction in 46% of women and 31% of men, underscoring the need for early recognition and sex-specific evaluation.

Research institutions are introducing propagation and cultivation technologies to change the supply structure of medicinal plants that have long depended on imports or wild harvesting. Aristolochia contorta, the source plant of Asarum, now has a stable tissue-culture propagation method, and pretreatment technology has also been proposed to improve the growth of Artemisia annua and the productivity of the key ingredient used in antimalarial treatment. This trend goes beyond simply accumulating research results; it reflects growing recognition that unstable raw material procurement has become a bottleneck for the broader bio and traditional Korean medicine industries. If cultivation can be standardized and alternative production methods established, it would reduce overharvesting of rare resources while supplying industrial raw materials with consistent quality, easing the long-standing conflict between conservation and commercialization.

Health functional foods are increasingly becoming everyday consumer goods chosen in small quantities at nearby stores and familiar platforms, rather than products people go out of their way to buy at specialty retailers. Convenience stores’ low-priced, small-pack products have sold quickly, pushing cumulative sales past 1.3 million units, while some companies have even decided to shut down their own online malls as of September 4 and shift sales toward external distribution networks. This trend is being driven by the expansion of health management from regular purchases by middle-aged consumers to more frequent, casual purchases by younger consumers. Wellness consumption has spread especially among those aged 15 to 24, and as spending on general-purpose health functional foods declines while demand for purpose-specific ingredients rises, distributors are emphasizing accessibility and ease of choice over price.

Among pharmaceutical manufacturers, the ability to keep factories running steadily has become a more decisive factor for performance and trust than research achievements. Samsung Biologics posted consolidated second-quarter revenue of 1.3209 trillion won and operating profit of 586.4 billion won this year, while Hanmi Pharmaceutical also improved supply stability by reducing cases of its own products being out of stock for more than five days... This trend has emerged because, in both biopharmaceuticals and essential medicines, production disruptions can immediately lead to quality deterioration or damage to market trust. In the end, manufacturing competitiveness is interpreted not simply as a cost issue, but as a core business capability encompassing order retention, client defense, and regulatory response.

Everyday biological signals that repeatedly appear in daily life, such as sleep and blood sugar, are being reinterpreted as tools for detecting early clues to disease. In particular, the link between locus coeruleus activity and REM sleep brain waves, increased micro-awakenings in middle-aged adults, and atypical symptoms such as nocturia and chronic fatigue that can appear even without snoring suggest the possibility of identifying neurodegenerative diseases and sleep disorders at an earlier stage. This trend is moving beyond simple measurement toward automated interpretation. As seen in the collaboration between Lingo and Google Health, connecting blood sugar, sleep, and activity data on a single screen makes it possible to read health abnormalities within overall lifestyle patterns rather than as isolated events, increasing the practicality of prevention-centered care.

Health-related consumption is shifting away from simply adding more beneficial products toward first reducing elements seen as burdensome. In fact, order value for zero-related products rose 523% compared with the same period two years earlier, showing that everyday decisions to manage sugar, additives, and processing burdens have moved to the center of the market, more than functionality itself. This change is less a passing trend than the result of a shift in the language consumers use to interpret health. Whereas general nutritional supplementation once worked, purchasing standards are now becoming more segmented around what to remove and what to selectively choose based on individual eating habits and physical condition.